ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
Price:
20.83
USD
-6.09%
Market Closed
Market Cap:
$3.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
|
US |
|
G
|
Global Payments Inc
LSE:0IW7
|
US |
|
Capcom Co Ltd
OTC:CCOEF
|
JP |
|
B
|
Bidvest Group Ltd
JSE:BVT
|
ZA |
|
Novozymes A/S
F:NZM
|
DK |
|
S
|
Swiss Re AG
SWB:SR9
|
CH |
|
Airbus SE
F:AIRA
|
NL |
|
8
|
8x8 Inc
XMUN:EGT
|
US |
|
B
|
Banco Santander SA
SWB:BSD2
|
ES |
|
Givaudan SA
SIX:GIVN
|
CH |
|
A
|
Amgen Inc
XMUN:AMG
|
US |
|
U
|
United Parcel Service Inc
LSE:0R08
|
US |
|
C
|
Continental AG
XHAN:CON
|
DE |
|
Bank Central Asia Tbk PT
IDX:BBCA
|
ID |
|
D
|
Darden Restaurants Inc
LSE:0I77
|
US |
|
Daikin Industries Ltd
TSE:6367
|
JP |
|
Alcoa Corp
NYSE:AA
|
US |
|
F
|
Fresenius Medical Care AG & Co KGaA
XHAM:FME
|
DE |
|
D
|
Deutsche Bank AG
DUS:DBK
|
DE |
Multiples-Based Value
The Multiples-Based Value for ACADIA Pharmaceuticals Inc (ACAD) under the Base Case is hidden
USD.
Compared with the current market price of 20.83 USD, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ACAD Multiples-Based Value
LOCKED